Martin Dekker - 26 Jan 2022 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
VP OF ENGINEERING & MANUFACTUR
Signature
/s/ Martin Dekker
Issuer symbol
BLPH
Transactions as of
26 Jan 2022
Transactions value $
$0
Form type
4
Filing time
28 Jan 2022, 15:31:08 UTC
Next filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLPH Restricted Stock Units Award $0 +51,000 $0 51,000 26 Jan 2022 Common Stock 51,000 $0 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest 50% on December 9, 2022 and 50% on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
F2 Not applicable.